Comparison of Mirabegron and Imidafenacin for efficacy and safety in Japanese female patients with overactive bladder: A randomized controlled trial (COMFORT Study).

Trial Profile

Comparison of Mirabegron and Imidafenacin for efficacy and safety in Japanese female patients with overactive bladder: A randomized controlled trial (COMFORT Study).

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Oct 2016

At a glance

  • Drugs Mirabegron (Primary) ; Imidafenacin
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Acronyms COMFORT
  • Most Recent Events

    • 26 Sep 2016 Status changed from active, no longer recruiting to completed.
    • 12 May 2015 Planned End Date changed to 31 Mar 2015 as reported by University Hospital Medical Information Network - Japan record.
    • 27 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top